In this report, “Intuitive Surgical,” “Intuitive,” the “Company,” “we,” “us,” and “our” refer to Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries. Product and brand names and logos, including Intuitive, da Vinci, and Ion, are trademarks or registered trademarks of Intuitive Surgical, Inc. or one of its subsidiaries or of their respective owners. Additional information about our trademarks can be found on our website at www.intuitive.com/trademarks. Although we reference our trademarks located on our website, this list of trademarks and any other materials on our corporate website are not incorporated by reference into this Form 10-K or any of our other filings under the Securities Act of 1933, as amended, or the Exchange Act. As part of Intuitive’s mission, we believe that minimally invasive care is life-enhancing care. By combining ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 10.1B | 10.1B | 8.4B | 7.1B | 6.2B | 5.7B |
| Net Income | 2.9B | 2.9B | 2.3B | 1.8B | 1.3B | 1.7B |
| EPS | $7.87 | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 |
| Free Cash Flow | 2.5B | 2.5B | 1.3B | 750M | 958M | 1.7B |
| ROIC | 17.1% | 20.2% | 15.9% | 19.4% | 17.9% | 20.4% |
| Gross Margin | 66.0% | 66.0% | 67.5% | 66.4% | 67.4% | 69.3% |
| Debt/Equity | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 2.9B | 2.9B | 2.3B | 1.8B | 1.6B | 1.8B |
| Operating Margin | 29.3% | 29.3% | 28.1% | 24.8% | 25.3% | 31.9% |
| ROE | 16.0% | 16.7% | 14.1% | 13.5% | 12.0% | 14.3% |
| Shares Outstanding | 363M | 363M | 362M | 357M | 362M | 366M |
INTUITIVE SURGICAL INC passes 5 of 9 quality checks, suggesting mixed fundamentals.
INTUITIVE SURGICAL INC trades at 58.3x trailing earnings, compared to its 15-year median P/E of 69.5x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 66.9x vs a median of 68.6x. The company's 5-year average ROIC is 18.8% with a gross margin of 67.3%. Total shareholder yield (buybacks) is 1.4%. At current prices, the estimated annualized return to fair value is +3.6%.
INTUITIVE SURGICAL INC (ISRG) has a current P/E ratio of 58.3, compared to its historical median P/E of 69.5. The stock is currently considered Fair based on its historical valuation range.
INTUITIVE SURGICAL INC (ISRG) has a 5-year average return on invested capital (ROIC) of 18.8%. This indicates strong capital allocation and a potential competitive advantage.
INTUITIVE SURGICAL INC (ISRG) has a market capitalization of $166.6B. It is classified as a large-cap stock.
INTUITIVE SURGICAL INC (ISRG) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 1.38%.
Based on historical P/E analysis, INTUITIVE SURGICAL INC (ISRG) appears fair. The current P/E of 58.3 is 16% below its historical median of 69.5. The estimated fair value CAGR (P/E method) is 13.4%.
INTUITIVE SURGICAL INC (ISRG) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, within the Healthcare sector.
INTUITIVE SURGICAL INC (ISRG) reported annual revenue of $10.1 billion in its most recent fiscal year, based on SEC EDGAR filings.
INTUITIVE SURGICAL INC (ISRG) has a net profit margin of 28.4%. This is a strong margin indicating high profitability.
INTUITIVE SURGICAL INC (ISRG) generated $2.5 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
INTUITIVE SURGICAL INC (ISRG) has a debt-to-equity ratio of 0.03. This indicates a conservatively financed balance sheet.
INTUITIVE SURGICAL INC (ISRG) reported earnings per share (EPS) of $7.87 in its most recent fiscal year.
INTUITIVE SURGICAL INC (ISRG) has a return on equity (ROE) of 16.7%. This indicates the company generates strong returns for shareholders.
INTUITIVE SURGICAL INC (ISRG) has a 5-year average gross margin of 67.3%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 19 years of financial data for INTUITIVE SURGICAL INC (ISRG), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
INTUITIVE SURGICAL INC (ISRG) has a book value per share of $49.12, based on its most recent annual SEC filing.